The insider selling, while notable in absolute dollars, is moderate relative to market cap and appears tied to option exercises. No bearish read-through is warranted. Monitor for any upcoming corporate announcements or earnings that could provide context for why key executives executed sales at this juncture.
AXSM drugs
AXSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 12 $255.17entry
- T+1 · 5mo ago −0.69%α −2.46% · $253.40
- T+5 · 5mo ago −1.83%α −2.50% · $250.50
- T+20 · 4mo ago −8.37%α −10.15% · $233.80
- T+60 · 2mo ago −18.56%α −21.82% · $207.82
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider sales at Axsome Therapeutics (AXSM) over the past week totaled ~$20.2M in open-market transactions, led by CEO Herriot Tabuteau ($12.0M) and CFO Nick Pizzie ($7.9M). Director-level sales were minor. At 0.16% of market cap, the selling is modest and likely reflects planned exercises and diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- CEO sold 49,670 shares at $241.01 for $11.97M on June 9.
- CFO sold 33,000 shares at $240.09 for $7.92M on June 9.
- Three directors sold aggregate ~$304K in small lots.
- Total open-market selling cluster value: ~$20.2M (0.16% of $12.7B market cap).
- All CEO and CFO sales followed derivative exercises (non-cash), consistent with planned transactions.
- No material corporate news or catalyst identified in the filing window.
Financial Impact
~$20.2M in insider open-market sales over 2 days, representing 0.16% of market cap, modest and routine.
Risk Factors
- If future filings reveal a lack of pre-arranged trading plans, the selling could indicate reduced confidence.
- Continued insider selling at current levels might pressure sentiment among retail holders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AXSM-1781224472996 |
Track record
26 reports on AXSM
6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 No price data
- Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
- Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
- Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
- Aug 10, 202614w ago 8-K Neutral 6/10 No price data
- Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
- Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
- Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
- Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
- Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers